Jubilant Pharmova Limited announced its active pharmaceutical engagement (API) business from September 1, 2025 to successfully sell and transfer the business of the company’s full -ridden subsidiary of the company, Jubilant Biosys Limited (“JBL”). This step is according to the terms of the Business Transfer Agreement (“BTA”).
The information of this transaction was earlier given in the company’s letter of June 12, 2025, and has been attached as Annexure A.
This information is the company’s website www.jubilantpharmova.com It is also available.
The company has requested the National Stock Exchange of India Limited and BSE Limited to take the above information on record and accept the receipt of this communication.
The program took place on 1 September 2025 at 04:20 pm (IST).
The announcement has been signed by Naresh Kapoor, a company secretary and Complication Officer of Jubilant Pharmova Limited.
The company’s registered office is located in Bharatigram, Gajraula, District Amroha 244 223, UP, India.
Corporate Identity Number (CIN) is L24116UP1978Plc004624.
Jubilant Pharmova Limited, Jubilant Bhartia is a company.